Tralokinumab treatment in patients with moderate-to-severe atopic dermatitis (AD) does not increase Covid-19 severity or interfere with Covid-19 vaccinations, according to a new study.
New study shows digital intervention may increase treatment adherence in AD patients
A digitally delivered intervention showed significant improvements in treatment adherence and other clinical outcomes in atopic dermatitis (AD) patients, according to a new study.
Black HS patients experience worse outcomes than White patients
According to a new study, Black hidradenitis suppurativa (HS) patients are more likely to experience greater disease severity, hospitalizations, emergency department visits and surgeries than White patients.
Real world study shows apremilast safe to treat PsO, PsA patients
A real-world study of psoriasis (PsO) and psoriatic arthritis (PsA) patients with apremilast reported no new adverse events or safety signals with results comparable to previous clinical trials.
Suppressing key metabolic enzyme may stop melanoma growth, new study shows
A new study has discovered that by inhibiting the key metabolic enzyme Glutaryl-CoA Dehydrogenase (GCDH), melanoma cells can be selectively killed to halt tumour growth.
Monkeypox infection may increase risk of cellulitis, new study shows
Researchers evaluated two cases of monkeypox infection where patients were also diagnosed with a deep skin bacterial infection. Investigators believe the progression of skin lesions with ulceration may be an entry point for bacteria, according to the study.
Study shows IL-23 inhibitors effective in biologic-naïve and non-naïve psoriasis patients
A new real-world study showed IL-23 inhibitors to be highly effective for the treatment of chronic plaque psoriasis in both biologic-naïve and biologic-non-naïve patients.
Researchers identify immune biomarker that may predict development of pediatric AD
New research has identified an immune biomarker in newborns that may predict the onset and severity of pediatric atopic dermatitis (AD).
New study suggests many pre-invasive melanoma may not be harmful
According to a new study, many pre-invasive melanoma or melanoma in situ may not be harmful or require treatment and are overly diagnosed.
New study highlights significant QoL impairment in patients with photoaggravated AD
According to a recent study, photoaggravated atopic dermatitis (PAD) severely impacts quality of life for patients.
HealthMinute.TV 